David is a London-based entrepreneur and investor in disruptive technologies and previously Managing Director of Expadis Capital. Prior to becoming an investor, he co-founded a publicly traded digital media company. David has extensive experience in building, advising technology companies and helping businesses scale internationally. David holds a BSc (Hons) in Engineering from the University of Liverpool and MA (Distinction) in Management from the University of Brighton.
Mr. Ivany was previously the president and CEO of a publicly traded company that, during his tenure, expanded in valuation from $2-million in market capitalization to over $250-million at its zenith while generating significant investor liquidity along the way. Over the past year, he has spearheaded capital formation in excess of $15 million in various merchant banking mandates across the biotechnology, health and wellness, and technology sectors. Derek's recent postings include his appointment to the Advisory Board of Relay Medical Corp. where he was instrumental in assisting with its growth financing, and as founder and director of Holy Crap Brands Inc. which was acquired by Plant & Co Brands Ltd. where he is now assisting in guiding corporate development and strategy. Additionally, Mr. Ivany served as founder and President of Pilz BioScience Corp., a biotechnology company developing medicinal psychedelics for neuroinflammatory conditions with the initial focus indication being Autism Spectrum Disorder. Pilz BioScience was subsequently acquired by Nova Mentis Life Science Corp.
Mr. Davis is the President of Circa Capital Corp, a privately held merchant banking and financial advisory firm focused on proprietary investments, corporate finance, mergers & acquisitions, and corporate restructuring. Throughout his career he has acted as strategic advisor and founding investor to a number of growth oriented private and public companies. Jeff started his career in Investment Banking with Jennings Capital, a full-service Canadian Broker/Dealer. He is a graduate of the University of British Columbia.
Mr. Zelen is a serial entrepreneur who has over 27 years of experience in finance, investor relations, sales, and corporate development. He is founder and president of Senergy Communications Capital Inc. which focused on the public markets and is involved in investor relations, public relations and strategic marketing for the technology, cannabis, pharmaceutical, mining and oil and gas industries.
Mr. Zelen has served as officer and director of at least 12 publicly listed companies over the last 21 years. His business activities within the venture capital arena have enabled him to establish a network of contacts, accredited investors, angel investors and investment banking contacts throughout North America, Europe and Asia.
Over the last 23 years Mr Zelen has been involved in no less than a dozen startups including Diitalk Communications, a co-founder of Blockchain Intelligence Group and founding member of Next Level Health Sciences.
Corbin was instrumental in preparing much of the documentation and accounting for the company to complete the RTO on the TSX.V in 2013. Corbin Comishin is the principle CPA of C. Comishin & Associates Inc, where his firm currently prepares all the accounting documentation for the quarterly filings. Corbin has been Head of Audit Committee until recently. He has been working in public practice since 1994 and principal partner since 1998. He is an Alumnus of the University of Calgary with a BComm in Accounting and studied under the institute of Chartered Accountants for his accounting designation.
John D'Agostino is an American business executive and entrepreneur. He was previously a managing director at Alkeon Capital Management, a multibillion-dollar registered investment adviser. Prior to this, D'Agostino was known primarily for his involvement in the early development of the Dubai Mercantile Exchange. John received a Master's degree in Business Administration from Harvard Business School, he also studied Politics, Philosophy and Economics at Oxford University.
Dr. Hochwimmer is Chief Analyst at General Research, GmbH, a leading Munich-based securities research and analysis firm. Dr. Hochwimmer is a noted business consultant and academic responsible for aiding in the development of several highly profitable companies throughout Europe. He serves as the CEO of supraMAT Technologies AG, which is a business incubator for German technology companies. He founded leading German technical start-ups, such as Jenabatteries, SmartDyelivery and Trophosys. He is also a managing director of Microdrop Technologies, which is a globally leading 3D micro-printing company. Dr. Hochwimmer has earned advanced degrees in chemistry and mechanical engineering.